Basic Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Aug 14, 2017; 23(30): 5538-5548
Published online Aug 14, 2017. doi: 10.3748/wjg.v23.i30.5538
Table 1 Clinical and pathological characteristics of gastric cancer patients
Characteristicn (%)
Age (yr)
< 606 (54.5)
≥ 605 (45.5)
Sex
Male8 (72.7)
Female3 (27.3)
Lymph node metastasis
Negative6 (54.5)
Positive5 (45.5)
Histopathology
Adenocarcinoma11 (100)
Others0 (0)
Grade
Well/moderately differentiated5 (45.5)
Poorly differentiated6 (54.5)
Stage
Early2 (18.2)
Advanced9 (81.8)
Surgical therapy
Negative0 (0)
Positive11 (100)
Table 2 Differentially expressed microRNAs in gastric cancer cells treated with Yangzheng Sanjie decoction
miRNA IDFold change (YZSJD/control)
AGSHS-746T
hsa-let-7a-5p1.541.80
hsa-let-7d-3p1.661.53
hsa-let-7f-5p1.682.70
hsa-miR-7-5p1.562.03
hsa-miR-15a-5p1.662.04
hsa-miR-15b-5p1.623.26
hsa-miR-21-3p1.861.75
hsa-miR-22-3p1.581.78
hsa-miR-22-5p1.741.60
hsa-miR-25-3p1.741.76
hsa-miR-26b-5p1.641.80
hsa-miR-27a-3p2.071.59
hsa-miR-27b-3p1.551.66
hsa-miR-30a-5p1.714.65
hsa-miR-30b-5p1.551.73
hsa-miR-30d-5p1.671.98
hsa-miR-30e-3p1.521.77
hsa-miR-32-5p1.601.83
hsa-miR-92b-3p1.581.95
hsa-miR-98-5p1.511.55
hsa-miR-99a-5p1.731.56
hsa-miR-105-5p1.572.59
hsa-miR-125a-5p1.671.72
hsa-miR-139-5p2.351.91
hsa-miR-181b-5p1.782.68
hsa-miR-186-5p1.651.71
hsa-miR-192-5p-2.27-4.17
hsa-miR-193b-3p3.331.53
hsa-miR-212-3p1.811.67
hsa-miR-215-5p-2.94-4.76
hsa-miR-361-5p1.831.84
hsa-miR-374a-5p1.832.06
hsa-miR-450a-5p1.591.65
hsa-miR-452-5p1.612.58
hsa-miR-454-3p1.592.44
hsa-miR-4841.652.18
hsa-miR-514a-3p1.603.34
Table 3 Let-7a and c-Myc expression in gastric cancer tissue samples
TissueLet-7a
c-Myc
(-)(+)(++)(+++)P value(-)(+)(++)(+++)P value
Ca3710< 0.050245< 0.05
Pc08301631
N01644610